Literature DB >> 8177622

The cost of childhood chickenpox: parents' perspective.

T A Lieu1, S B Black, N Rieser, P Ray, E M Lewis, H R Shinefield.   

Abstract

The development of a varicella vaccine has raised questions about the cost effectiveness of vaccination, but little information on the costs of chickenpox exists. The purpose of this study was to evaluate medical costs and the value of work loss among families whose children had chickenpox. Interviews were conducted with 179 families who made advice nurse calls or urgent care clinic visits to three clinics in the Northern California Kaiser Permanente Medical Care Plan. Two-thirds of working mothers and one-third of working fathers missed work to care for children with chickenpox. The mean value of the work lost because of chickenpox was $293/family or $183/chickenpox case. The estimated costs of nonprescription medications were $20/family or $12.50/chickenpox case. Children were sick enough to need to stay home for only one-third as many days as chicken actually stayed home because of school exclusion policies. These empiric results differ from previous estimates of the medical and work loss costs of varicella and should be included in analyses of the cost effectiveness of proposed vaccination programs.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8177622     DOI: 10.1097/00006454-199403000-00001

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  5 in total

Review 1.  Varicella vaccination--a critical review of the evidence.

Authors:  S A Skull; E E Wang
Journal:  Arch Dis Child       Date:  2001-08       Impact factor: 3.791

2.  Burden of chickenpox on families: A study in Quebec.

Authors:  P De Wals; M Blackburn; M Guay; G Bravo; D Blanchette; M Douville-Fradet
Journal:  Can J Infect Dis       Date:  2001-01

3.  The burden of severe varicella in Spain, 1995--2000 period.

Authors:  Angel Gil; Antonio González; Itziar Oyagüez; María San Martín; Pilar Carrasco
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

4.  Safety and immunogenicity of single dose live attenuated varicella vaccine (VR 795 Oka strain) in healthy Indian children: a randomized controlled study.

Authors:  Monjori Mitra; Mma Faridi; Apurba Ghosh; Nitin Shah; Raju Shah; Suparna Chaterjee; Manish Narang; Nisha Bhattacharya; Gandhali Bhat; Harish Choudhury; Ganesh Kadhe; Amey Mane; Sucheta Roy
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

5.  Indirect costs associated with skin infectious disease in children: a systematic review.

Authors:  Irene Lizano-Díez; Jesús Naharro; Ilonka Zsolt
Journal:  BMC Health Serv Res       Date:  2021-12-11       Impact factor: 2.655

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.